Literature DB >> 11964100

Mesa Grande: a methodological analysis of clinical trials of treatments for alcohol use disorders.

William R Miller1, Paula L Wilbourne.   

Abstract

AIM: A 3-year update with 59 new controlled trials is provided for the ongoing Mesa Grande project reviewing clinical trials of treatments for alcohol use disorders. The project summarizes the current evidence for various treatment approaches, weighting findings differentially according to the methodological strength of each study.
DESIGN: The review includes 361 controlled studies that (1) evaluated at least one treatment for alcohol use disorders, (2) compared it with an alternative condition (such as a control group, a placebo, a brief intervention or an alternative treatment), (3) used a procedure designed to create equivalent groups before treatment and (4) reported at least one outcome measure of drinking or alcohol-related consequences. Studies were rated by two reviewers on 12 methodological criteria, and outcome logic was analyzed for the specific treatment modalities tested.
FINDINGS: Methodological quality of studies was significantly but modestly correlated with the reporting of a specific effect of treatment. Among psychosocial treatments, strongest evidence of efficacy was found for brief interventions, social skills training, the community reinforcement approach, behavior contracting, behavioral marital therapy and case management. For the first time, two pharmacotherapies also appeared among the most strongly supported approaches: opiate antagonists (naltrexone, nalmefene) and acamprosate. Least supported were methods designed to educate, confront, shock or foster insight regarding the nature and causes of alcoholism.
CONCLUSIONS: Treatment methods differ substantially in apparent efficacy. It would be sensible to consider these differences in designing and funding treatment programs.

Entities:  

Mesh:

Year:  2002        PMID: 11964100     DOI: 10.1046/j.1360-0443.2002.00019.x

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


  204 in total

Review 1.  Alcohol use of diabetes patients: the need for assessment and intervention.

Authors:  Patricia A Engler; Susan E Ramsey; Robert J Smith
Journal:  Acta Diabetol       Date:  2010-06-08       Impact factor: 4.280

Review 2.  Evidence-based practices for substance use disorders.

Authors:  Mark P McGovern; Kathleen M Carroll
Journal:  Psychiatr Clin North Am       Date:  2003-12

Review 3.  Choosing a behavioral therapy platform for pharmacotherapy of substance users.

Authors:  Kathleen M Carroll; Thomas R Kosten; Bruce J Rounsaville
Journal:  Drug Alcohol Depend       Date:  2004-08-16       Impact factor: 4.492

4.  Advancing recovery: implementing evidence-based treatment for substance use disorders at the systems level.

Authors:  Laura A Schmidt; Traci Rieckmann; Amanda Abraham; Todd Molfenter; Victor Capoccia; Paul Roman; David H Gustafson; Dennis McCarty
Journal:  J Stud Alcohol Drugs       Date:  2012-05       Impact factor: 2.582

Review 5.  Cognitive enhancement as a treatment for drug addictions.

Authors:  Mehmet Sofuoglu; Elise E DeVito; Andrew J Waters; Kathleen M Carroll
Journal:  Neuropharmacology       Date:  2012-06-23       Impact factor: 5.250

6.  Effects of interactive voice response self-monitoring on natural resolution of drinking problems: utilization and behavioral economic factors.

Authors:  Jalie A Tucker; David L Roth; Jin Huang; M Scott Crawford; Cathy A Simpson
Journal:  J Stud Alcohol Drugs       Date:  2012-07       Impact factor: 2.582

7.  'The human prerogative': a critical analysis of evidence-based and other paradigms of care in substance abuse treatment.

Authors:  Eric Broekaert; Mieke Autrique; Wouter Vanderplasschen; Kathy Colpaert
Journal:  Psychiatr Q       Date:  2010-09

8.  Modelling lifetime QALYs and health care costs from different drinking patterns over time: a Markov model.

Authors:  Carolina Barbosa; Benjamin Taylor; Christine Godfrey; Juergen Rehm; Steve Parrott; Colin Drummond
Journal:  Int J Methods Psychiatr Res       Date:  2010-06       Impact factor: 4.035

9.  New pharmacotherapies for treating the neurobiology of alcohol and drug addiction.

Authors:  Helen M Pettinati; Amanda R Rabinowitz
Journal:  Psychiatry (Edgmont)       Date:  2006-05

10.  The COMBINE Study-: An Overview of the Largest Pharmacotherapy Study to Date for Treating Alcohol Dependence.

Authors:  Helen M Pettinati; Raymond F Anton; Mark L Willenbring
Journal:  Psychiatry (Edgmont)       Date:  2006-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.